CYP2B6 (c.516G->T) and CYP2A6 (9B and/or 17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients

Journal article

Open access

Awewura KWARA, Margaret LARTEY, Kwamena W SAGOE, Naser L RZEK and Michael H COURT

British journal of clinical pharmacology, Vol.67(4), pp.427-436

2009

Handle:

https://hdl.handle.net/2376/101820

PMCID: PMC2679106

PMID: 19371316

Files and links (1)

url

https://doi.org/10.1111/j.1365-2125.2009.03368.xView

Published (Version of record) Open

Immunopathology

Infectious diseases

Pharmacology. Drug treatments

Viral diseases

Viral diseases of the lymphoid tissue and the blood. Aids

Biological and medical sciences

Medical sciences

Human viral diseases

Immunodeficiencies. Immunoglobulinopathies

Immunodeficiencies

11 Record Views

Title: CYP2B6 (c.516G->T) and CYP2A6 (9B and/or 17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients
Creators: Awewura KWARA - The Miriam Hospital, United States
Margaret LARTEY - University of Ghana Medical School, Accra, Ghana
Kwamena W SAGOE - University of Ghana Medical School, Accra, Ghana
Naser L RZEK - Division of Pharmacology and Experimental Therapeutics, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Michael H COURT - Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, United States
Publication Details: British journal of clinical pharmacology, Vol.67(4), pp.427-436
Academic Unit: Veterinary Clinical Sciences, Department of
Publisher: Blackwell; Oxford
Identifiers: 99900546792401842
Language: English
Resource Type: Journal article